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Matrix metalloproteinases (MMPs) are zinc-dependent
endopeptidases which degrade extracellular matrix pro-
teins and modulate cell proliferation, migration, differen-
tiation and angiogenesis. MMP-2, a member of the
gelatinase subfamily of MMPs, participates in the remo-
deling and resolution of tissue injury and tumorigenesis.
We recently identified an unexpected new role for MMP-
2 in the modulation of innate immune function and in
the differentiation of inflammatory TH2 responses in the
tumor microenvironment [1]. Pre-exposure to MMP-2
inhibits IL-12 function and up-regulates OX40L expres-
sion by human dendritic cells (DCs). Enzymatically active
MMP-2 causes degradation of the IFNAR1 chain of the
type-I IFN receptor, reducing the ability of IFN beta to
enhance transcription of the IL-12p35 subunit through
STAT1 phosphorylation. In the absence of IL-12, OX40L
now functions as a key co-stimulatory molecule for the
priming of TH2 cells. Indeed, we have identified TH2 cells
within the TIL compartment of melanoma specimens
that produce IL-4, TNF and IL-13. However, the TH2
mechanism by which MMP-2 up-regulates OX40L is not
known and the role of MMP-2-driven TH2 cells in vivo
has not been determined. In this study, we specifically
investigated how MMP-2 up-regulates OX40L on DCs to
drive type-2 polarization and the physiologic role of
MMP-2 imprinted DC in driving TH2 cells. We identified
a novel physiological receptor, namely TLR2, for MMP-2
on DCs that, upon activation, up regulates OX40L and
induces the production of TNF and IL-6. Significantly,
MMP-2 acted as an adjuvant to prime TH2 cells in vivo
towards protein antigens. Therefore, extracellular MMP-
2 including that derived from tumors has the potential to
locally affect DCs leading to modulation of immune
responses in malignant diseases.
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